All Pharmaceutical Microbiology articles – Page 2
-
NewsStudy identifies potential novel drug to treat tuberculosis
A new study demonstrates that a novel semi-synthetic compound can be derived from natural compounds to produce potent activity against Mycobacterium tuberculosis, including multi-drug resistant strains.
-
NewsPlant compound used in traditional medicine may help fight tuberculosis
A compound found in African wormwood — a plant used medicinally for thousands of years to treat many types of illness — could be effective against tuberculosis, according to a new study.
-
NewsNew images of RSV may expose stubborn virus’s weak points
Using cryo-electron tomography, researchers have revealed details of molecules and structures essential to RSV’s form and function.
-
NewsHigh-throughput modular click chemistry synthesis of catechol derivatives to target Covid protease
Researchers performed high-throughput synthesis of catechol derivatives from the bioactive catechol-terminal alkyne scaffold A4, by using modular click chemistry, in a bid to target the Covid virus’s 3C-like protease (3CLpro).
-
NewsScientists design new drug to fight malaria
Scientists have designed a new drug against malaria and identified its mechanism of action. MED6-189 is effective against drug-sensitive and drug-resistant P. falciparum strains in vitro as well as in a humanized mouse model.
-
CareersFarm gates and facial fungi: Tanu charts her journey towards commercialisation
AMI Global Ambassador for New Zealand Tanushree Gupta is bringing an antifungal product to market that will make a huge difference to the hundreds of farms affected by facial eczema - so here’s how it’s going.
-
NewsStudy probes industrial scale lactoferrin production with synthetic biological systems
A new study explores the innovative technologies developed to increase lactoferrin production in order to meet market demand in food, pharma, and cosmetics.
-
NewsStudy IDs novel small-molecule inhibitors of SARS-CoV-2 with chemical genetics
A new article discusses the identification of novel small-molecule inhibitors of SARS-CoV-2 by chemical genetics.
-
NewsEradivir closes $10.25M Series A funding round for next stage of influenza therapeutic trials
Eradivir, a preclinical biotech company that develops antiviral therapeutics, has completed a $10.25 million Series A funding round which will be used to conduct a Phase 2a challenge study of its EV25 influenza treatment.
-
NewsTen different pharmaceuticals detected in corals in the Gulf of Eilat
A new study has detected traces of 10 common medications in coral samples collected from both shallow and deep sites in the Gulf of Eilat. Sulfamethoxazole, an antibiotic used for respiratory and urinary tract infections, was found in as many as 93% of the sampled corals.
-
NewsResearchers identify new tools for anti-Acinetobacter drug development and AMR preparedness
Researchers have engineered a library of strains that can be used to develop new antibacterial compounds to help address antimicrobial resistance (AMR) in Acinetobacter baumannii bacteria.
-
NewsAn antidiabetic helps the immune system recognize reservoirs of HIV
Metformin, a drug used to treat type 2 diabetes, could help deplete the viral reservoir and eliminate it entirely in people living with HIV who receive antiretroviral therapy, a new study reveals.
-
NewsConscience announces top performers in open science challenge to design promising pan-coronavirus drugs
The nonprofit drug discovery biotech Conscience has released seven newly discovered promising early-stage molecules that could lead to a new treatment effective against all coronaviruses, not just SARS-CoV-2.
-
NewsResearcher helps develop new technique to explore oceanic microbes
A new method makes it possible to collect microbial natural products where they are produced in the wild, without the need for lab culture. It uses an absorbent resin called HP-20, which acts like a sponge to capture the chemicals released by microbes.
-
NewsNew guideline for Helicobacter pylori includes change to primary treatment recommendation
New guidelines on the treatment of Helicobacter pylori (H. pylori) infection warn against prescribing PPI triple therapy, instead advising practitioners to use bismuth quadruple therapy or one of the other suggested treatment options.
-
NewsPublic health experts put out call for collaboration in antiviral therapeutics development coalition
Establishing a global therapeutics development coalition is a vital next step to invigorate the therapeutics pipeline and drive advocacy for increased investment and coordination of end-to-end therapeutics development, say a group of public health experts.
-
NewsScientists seek more effective treatment for under-the-radar STI
Researchers at Tulane University are leading a groundbreaking study to seek a more effective treatment for trichomoniasis, an infection that, despite being the most common curable sexually transmitted infection (STI) worldwide, continues to fly under the radar.
-
NewsNew microbial fermentation manufacturing facility launched in Billingham
The UK’s life science sector has been bolstered by a £100m investment by FUJIFILM Diosynth Biotechnologies. This takes the form of a new microbial fermentation manufacturing facility in Billingham.
-
NewsDairy farmer study reveals need for greater One Health understanding in AMR management
A new study has found a need for greater engagement and collaboration between veterinarians, farmers and regulators to improve understanding and management of antimicrobial resistance and One Health amongst Aotearoa New Zealand farmers.
-
NewsNanoparticle platform offers step toward more effective Covid and HIV vaccines
Researchers have developed a nanoparticle platform that could make existing vaccines more effective, including those for influenza, COVID-19, and HIV.
